You need to join the dots together. Why would such a high power high caliber person like Dr. Rosenblatt, ex CMO of Merck joining a tiny company such as PYC at this time@Medicine Man
Talking about dot joining, it would appear from the structure of the options that Dr Rosenblatt is making a long term commitment to PYC. One would imagine that the appointment not only reflects the excitement around the lead drug under development for retinitis pigmentosa type 11 but the capability of PYC to become a global player in the emergent field of RNA therapeutics.
Medicine Man has identified the AAV vs PYC's CPP contest as a key point of differentiation between PYC and almost everybody else in the field. The fact that Dr Rosenblatt has joined a tiny company such as PYC highlights the promise of the delivery platform to make a difference. If he can see it, who else will see it.
PYC Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)